Functional Outcomes and Health Related Quality of Life in Upper-extremity Sarcoma Patients After Limb Salvage: a Prospective Study
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Cancer of Muscle
- Sponsor
- Helsinki University Central Hospital
- Enrollment
- 55
- Locations
- 2
- Primary Endpoint
- Health-related quality of life and upper-extremity functional capability
- Status
- Completed
- Last Updated
- 5 years ago
Overview
Brief Summary
This study aims to assess the functional ability and health-related quality of life (HRQoL) of upper extremity sarcoma patients who have undergone limb salvage surgery.
Detailed Description
The purpose of this study is to assess the functional capabilities and health-related quality of life (HRQoL) of upper-extremity sarcoma patients who have undergone limb salvage surgery. Patient hospital records are retrospectively reviewed for demographic and clinical data. The patient recruitment takes place at the outpatient clinic of the Comprehensive Cancer Center, Helsinki University Hospital, and Tampere University Hospital. The study includes a cross-sectional assessment at six months follow-up with five validated questionnaires. A follow-up is conducted two and five years after surgery in the outpatient clinic.
Investigators
Jussi Repo
MD
Helsinki University Central Hospital
Eligibility Criteria
Inclusion Criteria
- •Upper extremity soft tissue sarcoma locating in between scapula to arm
- •No metastasis at the time of diagnosis
- •Undergone limb salvage surgery
- •A minimum of 6 months follow-up
- •Written consent
- •Age \> 18
Exclusion Criteria
- •No limb-salvage surgery due to sarcoma
Outcomes
Primary Outcomes
Health-related quality of life and upper-extremity functional capability
Time Frame: 6 months to five years
To assess health-related quality of life and upper-extremity functional capability
Secondary Outcomes
- The MSTS upper extremity section(6 months to five years)
- the 15D health-related quality of life instrument(6 months to five years)
- The QuickDASH(6 months to five years)
- Sarcoma recurrence(6 months to five years)
- Quality of Life Questionnaire-Core 30(6 months to five years)
- The TESS upper extremity section(6 months to five years)